SCHEMBL1675153

SCHEMBL1675153

OCCc1ccc(-c2ccc3ncnc(NCc4cccs4)c3c2)o1

nearest known ligand 0.85

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CLK4 Q9HAZ1 20/20 0.85
DYRK1A Q13627 9/20 0.85
CLK1 P49759 4/20 0.65
CLK2 P49760 3/20 0.65
DYRK1B Q9Y463 3/20 0.65
ALDH1A1 P00352 8/20 0.61
LMNA P02545 8/20 0.61
CYP2C19 P33261 8/20 0.61
CYP2D6 P10635 7/20 0.61
CYP1A2 P05177 7/20 0.61
CYP3A4 P08684 7/20 0.61
HSD17B10 Q99714 6/20 0.61
HIF1A Q16665 5/20 0.61
USP2 O75604 5/20 0.61
MEN1 O00255 2/20 0.61
KMT2A Q03164 2/20 0.61
TSHR P16473 6/20 0.60
CYP2C9 P11712 5/20 0.60
MAPK1 P28482 4/20 0.60
RECQL P46063 3/20 0.60

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1675050 0.92 CLK4 (1.00) CLK4DYRK1ACLK1CLK2DYRK1B
SCHEMBL1675108 0.85 CLK4 (0.62) CLK4DYRK1ACLK1CLK2DYRK1B
SCHEMBL1675091 0.84 CLK4 (0.72) CLK4DYRK1ACLK1CLK2DYRK1B
SCHEMBL1675052 0.83 CLK4 (1.00) CLK4DYRK1ACLK1CLK2DYRK1B
SCHEMBL1675016 0.82 CLK4 (0.84) CLK4DYRK1ACLK1CLK2DYRK1B
SCHEMBL1675183 0.82 CLK4 (0.60) CLK4DYRK1ACLK1CLK2DYRK1B
SCHEMBL1675337 0.79 CLK4 (1.00) CLK4DYRK1ACLK1CLK2DYRK1B
SCHEMBL1675203 0.77 CLK4 (0.73) CLK4DYRK1ACLK1CLK2DYRK1B
SCHEMBL1675326 0.76 CLK4 (0.66) CLK4DYRK1ACLK1CLK2DYRK1B
SCHEMBL1675126 0.75 CLK4 (1.00) CLK4DYRK1ACLK1CLK2DYRK1B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011041655-A1 QUINAZOLIN-4-AMINE DERIVATIVES; AND METHODS OF USE THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) 2011-04-07 WO claimed
WO-2011041655-A1 QUINAZOLIN-4-AMINE DERIVATIVES; AND METHODS OF USE THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) 2011-04-07 WO disclosed